Rubicon Research shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters51.25%−8.51 pts
Foreign investors (FII)9.01%+1.49 pts
Domestic institutions (DII)15.72%+6.29 pts
of which mutual funds13.78%+6.55 pts
of which insurance companies0.16%
Public24.02%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

RUBICON₹1,559.30

Rubicon Research Ltd.

· Pharma & Health
₹ CrorePeersSHILPAMEDSPARCSTARSUPRIYAPARKHOSPSTHYROCAREMETROPOLISMARKSANSMcap ₹25,742 Cr
Holding % of Total Shares
12 Months Ending
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group59.9959.8659.7651.25
FII / FPI7.997.547.529.01
DII9.4510.029.4315.72
Mutual Funds6.617.147.2313.78
Latest: 2026-09-30 · 5 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.